Europe’s Proposed Chemical Ban Could Hit Many Thousands Of Global Marketing Authorizations

 
• By Neena Brizmohun
  
Generate a summary of this article
Listen to this article
Beta

Drug manufacturing in the EU would grind to a halt in under three years if a proposal to restrict per- and polyfluoroalkyl substances in the European Economic Area is implemented in its current form, says industry group EFPIA.

drug manufacturing
Drug manufacturing in Europe could grind to a halt if a proposed chemical ban is implemented • Source: Shutterstock

At least 47,677 global drug marketing authorizations could be affected and over 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances in Europe is implemented, warned the European Federation of Pharmaceutical Industries Associations. 

Key Takeaways

  • Over 4,400 organizations, companies and individuals have responded to a consultation on a proposal from five EU countries to restrict per- and polyfluoroalkyl substances (PFAS) in the European Economic Area.

The proposal, which was prepared by five EU countries and underwent a public consultation that ended this week, aims...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By Saba Afreen

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     
    • By Anabel Costa-Ferreira and Ian Schofield

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography